Skip to main content
. Author manuscript; available in PMC: 2014 Oct 3.
Published in final edited form as: Int J Cardiol. 2013 Feb 8;168(3):2022–2028. doi: 10.1016/j.ijcard.2013.01.003

Table 1.

Summary on the effects of Algiysl-LVR™+CABG at different time points.

Patient 1
Patient 2
Patient 3
Baseline 3 months 6 months Baseline 3 months 6 months Baseline 3 months 6 months
EDV (ml) 197.4 98.2 98.2 367.6 244.7 228.2 94.6 93.8
ESV (ml) 122.4 34.0 23.7 280.4 173.3 148.1 50.1 35.7
SV (ml) 75.0 64.2 74.5 87.2 71.4 80.1 44.5 58.1
EF (%) 40 65.4 75.9 23.7 29.2 35.1 47.0 61.9
Sphericity index 0.74 0.61 0.56 0.72 0.7 0.77 0.73 0.67
Average thickness (cm) 1.12 1.52 1.65 0.83 1.02 1.24 1.35 1.58
Average ED stress (kPa) 5.6 3.1 3.1 8.7 6.4 5.4 3.6 2.8
Average ES stress (kPa) 29.6 12.7 9.4 52.4 37.4 29.4 19.3 12.8
Peak ES stress (kPa) 61.9 27.2 24.5 178.2 109.6 69.4 48.2 35.2